| 摘要 |
The invention provides pharmacological compositions comprising a stimulat or or activator of the soluble guanylate cyclase alone (sGC) or in combinati on with a PDE5 inhibitor for the treatment of urological disorders comprisin g of Benign Prostate Syndrome (BPS), Benign Prostate Hyperplasia (BPH), Beni gn Prostate Enlargement (BPE), Bladder Outlet Obstruction (BOO), Lower Urina ry Tract Symptoms (LUTS), genitourinary disorders comprising neurogenic blad der syndrome (OAB) and (IC), urinary incontinence (UI) like mixed-, urge-, s tress-, or overflow incontinence (MUI, UUI, SUI, OUI) and pelvic pain (PP).
|
